https://www.selleckchem.com/pr....oducts/ag-221-enasid
05); high-fat food had no significant effect on AUC0-t , AUC0-∞, or terminal elimination half-life of immediate-release tofacitinib tablets (all P .05). The 90% confidence intervals of the test/reference ratios of log-transformed maximum plasma concentration, AUC0-t , and AUC0-∞ were within the range of 80% to 125% under both fasting and fed conditions. No serious adverse events were reported. The 2 formulations of immediate-release tofacitinib tablets are bioequivalent and well tolerated under both fasting and fed condit
Like
Comment
Share
